Palisade Bio Inc. (PALI)
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
HCA Healthcare - HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
Alto Ingredients, Inc. Added to Russell2000® and Russell 3000® Indexes
Achieve Life Sciences Joins Russell 2000® Index
Cycurion, Inc. Enters into Asset Purchase Agreement to Acquire Kustom Entertainment’s Legacy Video Solutions Segment, Delivering Non-Dilutive Scale, Access to Approximately 1,000 New Clients and a Robust Portfolio of Approximately 58 Patents
WeShop Added to Russell 3000® and Russell Microcap® Indexes
Stran Expands Strategic Casino Market Presence with Industry Veteran Kevin Lewis to Accelerate Growth and Client Impact
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
RXO Wins Prestigious “Best in Cargo Security” Award from CargoNet
Achieve Life Sciences Joins Russell 2000® Index